Skip to main content

Lanxess, Bayer to exit Currenta stake

21st August 2019

Submitted by:

Andrew Warmington

Lanxess and its former parent Bayer have signed an agreement to sell their respective 40% and 60% stakes in Currenta to funds managed by Australia-based Macquarie Infrastructure & Real Assets (MIRA). MIRA is said to be the world's largest infrastructure investor, with about €115 billion in assets under management.

Currenta manages and operates infrastructure, energy supply and other services across three German chemical parks at Leverkusen (pictured), Dormagen and Krefeld-Ürdingen. The deal, which gives it a total enterprise value of €3.5 billion, before deductions of net debt and pension obligations, is subject to regulatory approval. Lanxess expects to hold its stake, worth about €780 million net, until up to the end of April, during which time it will be entitled to a profit participation in Currenta.

As one of Currenta’s main customers at the sites, which account for a large part of its global operations, it will give MIRA operational support during the transition phase. The two have also concluded a ten-year service and supply agreement. “The heart of Lanxess production beats at the Lower Rhine sites. It was therefore crucial for us that the future Currenta owner structure should safeguard our strategic interest in an industry-oriented set-up of the chemical parks,” said Matthias Zachert, chairman of the board of management.

Bayer had been seeking to sell its €1.17 billion stake since November 2018, due mainly to the carve-out of Covestro and its changing focus, and it aims to exit earlier, within Q4 2019. It has concluded similar long-term service and supply contracts and is also selling Currenta a €180 million package of real estate and infrastructure.

Separately, Lanxess has agreed to sell its chrome chemicals business to Brother Enterprises, a Chinese leather chemicals producer, saying that it “no longer fits in with our strategic focus on speciality chemicals”. The business, part of the Leather business unit, produces sodium dichromate and downstream chromic acid and chrome-tanning salts at two sites in South Africa. Lanxess will continue to do produce the latter under a toll contract until 2024. 

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington